NEW CLASSES OF NEUROLOGICAL AND ANTIDEPRESSANTS, IN SOLID ORAL FORM, ORIENTED TO BOTH CONTRA (Q2035394): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item) |
||
Property / fund | |||
Property / fund: European Regional Development Fund / rank | |||
Normal rank |
Revision as of 18:40, 8 June 2020
Project in Italy financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | NEW CLASSES OF NEUROLOGICAL AND ANTIDEPRESSANTS, IN SOLID ORAL FORM, ORIENTED TO BOTH CONTRA |
Project in Italy financed by DG Regio |
Statements
1,489,557.14 Euro
0 references
2,979,114.26 Euro
0 references
50.0 percent
0 references
12 December 2016
0 references
6 July 2019
0 references
UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
0 references
ITC FARMA
0 references
L'IDEA PROGETTUALE CONSISTE NELLO SVILUPPO DI UN'AREA R&D E DI NUOVO IMPIANTO DI GRANULAZIONE INDUSTRIALE. LO SCOPO ? QUELLO DI RILANCIARE LA COMPETITIVIT? DELLA ITC FARMA SUL MERCATO DEI FARMACI GENERICI SEGUENDO DUE PERCORSI PARALLELI E SINERGICI, E (Italian)
0 references
The design idea is the development of an area R & d and new industrial granulation plant. THE PURPOSE? HOW TO BOOST COMPETITIVENESS? ITC FARMA ON THE GENERIC DRUG MARKET FOLLOWING TWO PARALLEL AND SYNERGISTIC PATHWAYS; (English)
0 references
Identifiers
F27H18000050007
0 references